Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of chronomodulated versus routine TPF induction chemotherapy with IMRT in locally advanced nasopharyngeal carcinoma
ChiCTR1800016809Phase 2Recruiting
- Sponsor
- Tumor Hospital Affiliated to Guizhou Medical University
- Start
- Apr 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of docetaxel, cisplatin and fluorouracil in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Tumor Hospital Affiliated to Guizhou Medical University. Primary endpoint: Side effects of chemotherapy and effect. Started Apr 2013; status: recruiting.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR1800016809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016809.